Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

ALX Oncology Holdings Inc. Common Stock

ALXO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ALXO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ALXO Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ALXO Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ALXO Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ALXO holdings by institutional investors

Quarterly net insider trading by ALXO's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ALXO

Quiver Logo

No former government officials on record as having lobbied for ALXO

Revolving Door Dashboard

ALXO Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ALXO Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ALXO Income Statement
ALXO Balance Sheet
ALXO Cash Flow
U.S. Patents

New ALXO patent grants

  • Patent Title: Combination therapies comprising an agent that blocks the interaction between cd47 and sirpα for treating gastric or gastroesphageal junction cancel Jan. 20, 2026
  • Patent Title: Antibodies against signal-regulatory protein alpha and methods of use Sep. 02, 2025
  • Patent Title: Combination therapies comprising a hypomethylation agent for treating cancer Jul. 01, 2025
  • Patent Title: Combination therapies for treating cancer Sep. 24, 2024
  • Patent Title: Antibodies against signal-regulatory protein alpha and methods of use Mar. 26, 2024
  • Patent Title: Activatable antibodies and methods of use thereof Mar. 26, 2024
  • Patent Title: Constructs having a sirp-α domain or variant thereof May. 02, 2023
  • Patent Title: Methods of treating cancer Mar. 28, 2023
  • Patent Title: Antibodies against signal-regulatory protein alpha and methods of use Aug. 02, 2022
  • Patent Title: Antibodies against signal-regulatory protein α and methods of use Apr. 05, 2022
  • Patent Title: Antibodies against signal-regulatory protein alpha and methods of use Feb. 08, 2022
  • Patent Title: Constructs having a sirp-alpha domain or variant thereof Dec. 28, 2021
  • Patent Title: Constructs having a sirp-alpha domain or variant thereof Jun. 30, 2020
  • Patent Title: Constructs having a sirp-α domain or variant thereof Apr. 16, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ALXO from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ALXO News

Recent insights relating to ALXO

CNBC Recommendations

Recent picks made for ALXO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ALXO

ALXO Analyst Ratings

ALXO Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ALXO Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ALXO stock a Buy, Sell, or Hold?

  • What is the price target for $ALXO stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ALXO Top Shareholders
Shareholder
Shares Held
ALXO Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ALXO stock?

  • Who owns the most shares of $ALXO stock?

  • What funds own $ALXO stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ALXO Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ALXO Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ALXO

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

  • Address South San Francisco, CA
  • Market Cap 221.2 million
  • Employees 48
  • Industrial Classification Pharmaceutical Preparations

ALX Oncology Holdings Inc. Common Stock (ALXO) Historical Stock Prices

ALX Oncology Holdings Inc. Common Stock (ALXO) closed at $1.60 on September 22, 2026. Over the past year its adjusted close ranged from $1.08 to $2.60. Daily prices go back to July 17, 2020, 1,553 trading days in all.

  • 1 month-21.57%
  • 3 months-9.09%
  • Year to date+41.59%
  • 1 year+25.98%
  • 3 years-68.19%
  • 5 years-97.97%
  • Max-94.67%
See every congressional and insider trade on the ALXO price chart

Quiver Premium charts ALXO's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 1.68 1.68 1.60 1.60 1.60 652,788
Sep 21, 2026 1.72 1.72 1.65 1.66 1.66 849,657
Sep 18, 2026 1.74 1.75 1.67 1.70 1.70 5,063,199
Sep 17, 2026 1.79 1.80 1.74 1.74 1.74 526,481
Sep 16, 2026 1.90 1.91 1.74 1.76 1.76 821,212
Sep 15, 2026 1.92 1.92 1.86 1.89 1.89 758,972
Sep 14, 2026 1.98 1.98 1.92 1.93 1.93 879,740
Sep 11, 2026 1.91 2.00 1.85 1.94 1.94 1,036,362
Sep 10, 2026 1.85 1.93 1.81 1.90 1.90 1,061,557
Sep 9, 2026 1.97 2.02 1.84 1.84 1.84 770,489
Sep 8, 2026 1.97 2.02 1.96 2.00 2.00 425,515
Sep 4, 2026 2.00 2.03 1.99 2.01 2.01 301,115
Sep 3, 2026 2.09 2.09 2.00 2.03 2.03 603,424
Sep 2, 2026 1.98 2.09 1.98 2.08 2.08 855,107
Sep 1, 2026 1.91 2.00 1.90 1.98 1.98 1,441,610
Aug 31, 2026 2.07 2.07 1.90 1.93 1.93 349,438
Aug 28, 2026 2.02 2.04 1.98 2.00 2.00 639,792
Aug 27, 2026 1.97 2.06 1.97 2.05 2.05 628,152
Aug 26, 2026 1.98 2.00 1.95 1.98 1.98 385,052
Aug 25, 2026 1.98 2.04 1.98 2.00 2.00 466,069
Aug 24, 2026 2.02 2.03 1.95 1.99 1.99 273,463
Aug 21, 2026 2.01 2.07 1.98 2.04 2.04 410,888
Aug 20, 2026 2.05 2.06 1.97 1.99 1.99 473,673
Aug 19, 2026 2.10 2.13 2.02 2.06 2.06 1,221,858
Aug 18, 2026 1.95 2.08 1.94 2.08 2.08 901,321
Aug 17, 2026 1.93 2.00 1.91 1.97 1.97 698,702
Aug 14, 2026 1.95 2.00 1.92 1.96 1.96 584,160
Aug 13, 2026 2.01 2.02 1.94 1.94 1.94 953,663
Aug 12, 2026 1.91 2.02 1.90 2.01 2.01 2,419,813
Aug 11, 2026 2.09 2.09 1.90 1.93 1.93 620,475
Aug 10, 2026 2.10 2.13 2.03 2.06 2.06 506,207
Aug 7, 2026 2.13 2.18 2.04 2.10 2.10 8,493,579
Aug 6, 2026 1.94 2.14 1.87 2.11 2.11 580,906
Aug 5, 2026 1.98 2.02 1.90 1.92 1.92 594,157
Aug 4, 2026 1.93 2.01 1.93 1.97 1.97 472,946
Aug 3, 2026 1.94 2.09 1.90 1.93 1.93 564,501
Jul 31, 2026 1.95 2.00 1.85 1.94 1.94 703,611
Jul 30, 2026 1.94 2.00 1.94 1.95 1.95 424,565
Jul 29, 2026 1.97 2.03 1.90 1.95 1.95 444,802
Jul 28, 2026 2.09 2.09 1.91 1.99 1.99 328,438
Jul 27, 2026 2.03 2.11 2.01 2.02 2.02 364,713
Jul 24, 2026 2.03 2.08 1.97 2.03 2.03 1,011,372
Jul 23, 2026 1.97 2.04 1.94 2.02 2.02 428,201
Jul 22, 2026 2.03 2.04 1.95 2.02 2.02 580,322
Jul 21, 2026 1.91 2.09 1.91 2.05 2.05 729,237
Jul 20, 2026 2.09 2.13 1.91 1.92 1.92 488,010
Jul 17, 2026 2.04 2.16 1.99 2.10 2.10 765,312
Jul 16, 2026 2.04 2.07 1.90 2.07 2.07 791,879
Jul 15, 2026 1.99 2.06 1.92 2.03 2.03 669,826
Jul 14, 2026 2.00 2.02 1.91 2.00 2.00 767,635
Jul 13, 2026 2.08 2.13 1.94 1.97 1.97 1,216,887
Jul 10, 2026 2.08 2.17 2.00 2.12 2.12 781,671
Jul 9, 2026 2.33 2.41 2.05 2.06 2.06 776,526
Jul 8, 2026 2.36 2.40 2.27 2.33 2.33 1,760,444
Jul 7, 2026 2.20 2.40 2.17 2.36 2.36 1,816,667
Jul 6, 2026 2.06 2.27 2.03 2.19 2.19 1,386,799
Jul 2, 2026 2.08 2.12 2.02 2.07 2.07 1,067,437
Jul 1, 2026 2.04 2.11 1.98 2.06 2.06 1,230,987
Jun 30, 2026 2.22 2.22 2.05 2.07 2.07 1,014,560
Jun 29, 2026 2.00 2.25 1.95 2.20 2.20 2,189,501
Jun 26, 2026 1.79 2.13 1.76 2.04 2.04 14,472,419
Jun 25, 2026 1.81 1.91 1.74 1.79 1.79 936,798
Jun 24, 2026 1.75 1.81 1.70 1.79 1.79 932,657
Jun 23, 2026 1.60 1.79 1.59 1.76 1.76 1,015,691
Jun 22, 2026 1.54 1.66 1.54 1.63 1.63 958,625
Jun 18, 2026 1.44 1.54 1.41 1.53 1.53 5,048,971
Jun 17, 2026 1.37 1.46 1.37 1.45 1.45 1,294,432
Jun 16, 2026 1.59 1.59 1.38 1.38 1.38 2,946,927
Jun 15, 2026 1.59 1.61 1.56 1.58 1.58 1,638,392
Jun 12, 2026 1.52 1.60 1.49 1.58 1.58 642,637
Jun 11, 2026 1.43 1.55 1.43 1.52 1.52 529,233
Jun 10, 2026 1.53 1.59 1.46 1.46 1.46 708,108
Jun 9, 2026 1.58 1.62 1.52 1.55 1.55 502,044
Jun 8, 2026 1.57 1.60 1.54 1.57 1.57 664,068
Jun 5, 2026 1.58 1.64 1.52 1.54 1.54 858,473
Jun 4, 2026 1.66 1.75 1.55 1.56 1.56 2,844,000
Jun 3, 2026 1.77 1.80 1.67 1.67 1.67 710,233
Jun 2, 2026 1.76 1.82 1.69 1.78 1.78 859,915
Jun 1, 2026 1.89 1.89 1.79 1.80 1.80 1,016,290
May 29, 2026 1.90 1.98 1.89 1.90 1.90 704,830
May 28, 2026 1.97 1.99 1.89 1.89 1.89 1,132,496
May 27, 2026 1.92 2.02 1.86 1.96 1.96 4,239,117
May 26, 2026 1.98 2.00 1.90 1.93 1.93 2,096,534
May 22, 2026 1.99 2.02 1.95 1.98 1.98 1,168,012
May 21, 2026 1.99 2.02 1.97 1.99 1.99 531,152
May 20, 2026 1.96 2.00 1.93 1.99 1.99 438,872
May 19, 2026 1.98 1.99 1.88 1.96 1.96 628,975
May 18, 2026 2.04 2.07 1.95 2.00 2.00 827,334
May 15, 2026 2.00 2.06 1.93 2.03 2.03 468,128
May 14, 2026 2.04 2.09 1.97 2.04 2.04 406,044
May 13, 2026 2.04 2.10 1.95 2.03 2.03 565,063
May 12, 2026 2.08 2.19 2.01 2.03 2.03 595,764
May 11, 2026 2.06 2.13 2.01 2.08 2.08 891,797
May 8, 2026 1.89 2.10 1.76 2.08 2.08 998,765
May 7, 2026 2.09 2.10 1.85 1.87 1.87 652,024
May 6, 2026 1.91 2.09 1.91 2.09 2.09 691,043
May 5, 2026 1.91 1.98 1.85 1.93 1.93 673,239
May 4, 2026 1.72 1.91 1.71 1.88 1.88 708,456
May 1, 2026 1.71 1.91 1.69 1.69 1.69 1,241,028
Apr 30, 2026 1.59 1.71 1.59 1.70 1.70 567,302
Apr 29, 2026 1.64 1.67 1.56 1.58 1.58 394,276
Apr 28, 2026 1.59 1.66 1.55 1.64 1.64 768,260
Apr 27, 2026 1.67 1.70 1.54 1.59 1.59 1,228,865
Apr 24, 2026 1.60 1.67 1.51 1.67 1.67 858,924
Apr 23, 2026 1.71 1.71 1.55 1.59 1.59 1,299,410
Apr 22, 2026 1.74 1.75 1.67 1.70 1.70 2,425,659
Apr 21, 2026 1.77 1.77 1.68 1.70 1.70 1,143,681
Apr 20, 2026 1.67 1.80 1.65 1.75 1.75 2,242,280
Apr 17, 2026 1.66 1.75 1.65 1.67 1.67 1,834,780
Apr 16, 2026 1.69 1.70 1.66 1.68 1.68 511,340
Apr 15, 2026 1.62 1.70 1.60 1.68 1.68 1,138,430
Apr 14, 2026 1.75 1.82 1.61 1.61 1.61 661,309
Apr 13, 2026 1.68 1.91 1.67 1.75 1.75 1,353,445
Apr 10, 2026 1.68 1.77 1.60 1.70 1.70 2,596,949
Apr 9, 2026 1.91 1.93 1.65 1.70 1.70 3,355,211
Apr 8, 2026 1.87 1.94 1.81 1.90 1.90 442,393
Apr 7, 2026 1.94 1.97 1.76 1.83 1.83 1,159,308
Apr 6, 2026 1.98 2.01 1.94 1.96 1.96 674,694
Apr 2, 2026 1.94 2.04 1.94 1.97 1.97 415,130
Apr 1, 2026 2.04 2.05 1.97 1.98 1.98 380,113
Mar 31, 2026 1.93 2.04 1.93 2.00 2.00 384,513
Mar 30, 2026 2.04 2.04 1.80 1.91 1.91 768,170
Mar 27, 2026 2.03 2.04 1.99 2.04 2.04 276,453
Mar 26, 2026 2.03 2.09 1.97 2.04 2.04 435,951
Mar 25, 2026 2.03 2.20 1.95 2.04 2.04 1,208,288
Mar 24, 2026 2.17 2.23 2.02 2.04 2.04 1,162,681
Mar 23, 2026 2.16 2.21 2.07 2.20 2.20 913,536
Mar 20, 2026 2.19 2.27 2.13 2.18 2.18 1,268,459
Mar 19, 2026 2.17 2.27 2.04 2.19 2.19 1,244,460
Mar 18, 2026 2.17 2.18 2.08 2.15 2.15 800,191
Mar 17, 2026 2.05 2.24 2.05 2.17 2.17 436,267
Mar 16, 2026 2.00 2.17 1.96 2.08 2.08 424,131
Mar 13, 2026 2.04 2.04 1.96 1.98 1.98 371,864
Mar 12, 2026 2.14 2.14 1.99 2.02 2.02 295,677
Mar 11, 2026 2.05 2.15 2.04 2.15 2.15 334,657
Mar 10, 2026 2.18 2.30 2.02 2.04 2.04 446,238
Mar 9, 2026 2.21 2.26 2.01 2.13 2.13 647,373
Mar 6, 2026 2.16 2.36 2.13 2.21 2.21 1,224,124
Mar 5, 2026 2.20 2.26 2.11 2.13 2.13 340,176
Mar 4, 2026 2.07 2.25 2.04 2.19 2.19 423,210
Mar 3, 2026 2.04 2.23 2.02 2.07 2.07 501,822
Mar 2, 2026 2.02 2.29 2.02 2.12 2.12 657,968
Feb 27, 2026 2.14 2.21 2.01 2.11 2.11 1,022,680
Feb 26, 2026 2.42 2.47 2.24 2.35 2.35 2,289,879
Feb 25, 2026 2.52 2.61 2.39 2.42 2.42 786,891
Feb 24, 2026 2.41 2.65 2.37 2.45 2.45 364,763
Feb 23, 2026 2.43 2.53 2.36 2.42 2.42 252,103
Feb 20, 2026 2.59 2.60 2.38 2.45 2.45 498,222
Feb 19, 2026 2.33 2.66 2.20 2.60 2.60 3,296,744
Feb 18, 2026 2.27 2.37 2.21 2.32 2.32 244,874
Feb 17, 2026 2.15 2.35 2.12 2.27 2.27 446,958
Feb 13, 2026 2.42 2.50 2.21 2.21 2.21 490,724
Feb 12, 2026 2.45 2.62 2.23 2.40 2.40 699,047
Feb 11, 2026 2.56 2.60 2.31 2.48 2.48 809,310
Feb 10, 2026 2.32 2.60 2.18 2.55 2.55 1,688,492
Feb 9, 2026 2.08 2.42 1.98 2.34 2.34 1,184,025
Feb 6, 2026 2.16 2.25 1.99 2.05 2.05 706,706
Feb 5, 2026 2.10 2.41 1.97 2.06 2.06 2,496,788
Feb 4, 2026 1.88 2.17 1.88 2.01 2.01 1,365,747
Feb 3, 2026 1.70 2.00 1.66 1.87 1.87 1,333,037
Feb 2, 2026 1.66 1.81 1.65 1.68 1.68 250,805
Jan 30, 2026 1.82 1.93 1.63 1.74 1.74 2,238,494
Jan 29, 2026 1.36 1.65 1.36 1.57 1.57 550,748
Jan 28, 2026 1.51 1.51 1.36 1.37 1.37 110,733
Jan 27, 2026 1.45 1.56 1.43 1.50 1.50 130,358
Jan 26, 2026 1.42 1.49 1.39 1.48 1.48 103,888
Jan 23, 2026 1.48 1.49 1.40 1.40 1.40 85,552
Jan 22, 2026 1.48 1.51 1.44 1.47 1.47 252,842
Jan 21, 2026 1.32 1.48 1.32 1.47 1.47 254,180
Jan 20, 2026 1.16 1.36 1.16 1.32 1.32 280,251
Jan 16, 2026 1.22 1.27 1.16 1.17 1.17 204,477
Jan 15, 2026 1.33 1.40 1.21 1.21 1.21 241,598
Jan 14, 2026 1.50 1.50 1.31 1.33 1.33 282,441
Jan 13, 2026 1.46 1.56 1.44 1.49 1.49 198,415
Jan 12, 2026 1.41 1.49 1.37 1.44 1.44 243,406
Jan 9, 2026 1.27 1.40 1.25 1.35 1.35 277,485
Jan 8, 2026 1.18 1.34 1.18 1.24 1.24 312,607
Jan 7, 2026 1.09 1.22 1.08 1.18 1.18 164,737
Jan 6, 2026 1.11 1.17 1.07 1.08 1.08 220,249
Jan 5, 2026 1.16 1.18 1.08 1.12 1.12 690,278
Jan 2, 2026 1.13 1.16 1.09 1.15 1.15 121,959
Dec 31, 2025 1.18 1.19 1.13 1.13 1.13 281,615
Dec 30, 2025 1.25 1.27 1.19 1.19 1.19 180,752
Dec 29, 2025 1.35 1.35 1.26 1.26 1.26 96,467
Dec 26, 2025 1.35 1.37 1.27 1.33 1.33 74,640
Dec 24, 2025 1.42 1.42 1.34 1.36 1.36 69,963
Dec 23, 2025 1.48 1.48 1.39 1.40 1.40 43,509
Dec 22, 2025 1.49 1.53 1.45 1.49 1.49 101,423
Dec 19, 2025 1.44 1.50 1.44 1.45 1.45 131,809
Dec 18, 2025 1.48 1.56 1.40 1.41 1.41 291,336
Dec 17, 2025 1.44 1.51 1.39 1.45 1.45 220,672
Dec 16, 2025 1.38 1.50 1.37 1.43 1.43 128,733
Dec 15, 2025 1.46 1.50 1.40 1.40 1.40 222,037
Dec 12, 2025 1.51 1.54 1.46 1.47 1.47 96,843
Dec 11, 2025 1.54 1.55 1.50 1.52 1.52 85,627
Dec 10, 2025 1.48 1.57 1.45 1.54 1.54 214,458
Dec 9, 2025 1.45 1.52 1.41 1.47 1.47 166,778
Dec 8, 2025 1.54 1.60 1.40 1.44 1.44 410,564
Dec 5, 2025 1.37 1.48 1.37 1.42 1.42 266,319
Dec 4, 2025 1.33 1.40 1.30 1.37 1.37 147,668
Dec 3, 2025 1.27 1.33 1.20 1.32 1.32 346,445
Dec 2, 2025 1.32 1.35 1.20 1.20 1.20 223,768
Dec 1, 2025 1.33 1.41 1.30 1.32 1.32 193,523
Nov 28, 2025 1.38 1.43 1.35 1.37 1.37 42,778
Nov 26, 2025 1.45 1.47 1.35 1.38 1.38 143,660
Nov 25, 2025 1.52 1.54 1.45 1.45 1.45 85,989
Nov 24, 2025 1.43 1.55 1.43 1.51 1.51 166,923
Nov 21, 2025 1.35 1.45 1.29 1.43 1.43 178,057
Nov 20, 2025 1.51 1.56 1.36 1.36 1.36 167,667
Nov 19, 2025 1.65 1.66 1.47 1.47 1.47 286,894
Nov 18, 2025 1.55 1.63 1.53 1.63 1.63 327,933
Nov 17, 2025 1.39 1.65 1.36 1.56 1.56 739,375
Nov 14, 2025 1.20 1.47 1.18 1.38 1.38 826,017
Nov 13, 2025 1.27 1.35 1.19 1.22 1.22 401,046
Nov 12, 2025 1.30 1.32 1.22 1.28 1.28 155,680
Nov 11, 2025 1.27 1.35 1.18 1.31 1.31 350,764
Nov 10, 2025 1.27 1.35 1.25 1.27 1.27 254,581
Nov 7, 2025 1.21 1.41 1.05 1.38 1.38 758,147
Nov 6, 2025 1.26 1.36 1.13 1.18 1.18 824,612
Nov 5, 2025 1.50 1.53 1.25 1.26 1.26 546,714
Nov 4, 2025 1.52 1.60 1.46 1.46 1.46 303,479
Nov 3, 2025 1.57 1.64 1.54 1.57 1.57 166,038
Oct 31, 2025 1.52 1.55 1.49 1.54 1.54 99,872
Oct 30, 2025 1.57 1.61 1.52 1.55 1.55 123,047
Oct 29, 2025 1.54 1.61 1.51 1.59 1.59 197,553
Oct 28, 2025 1.66 1.68 1.53 1.54 1.54 254,685
Oct 27, 2025 1.75 1.77 1.62 1.70 1.70 410,241
Oct 24, 2025 1.80 1.90 1.71 1.75 1.75 443,578
Oct 23, 2025 1.65 1.84 1.63 1.75 1.75 659,655
Oct 22, 2025 1.61 1.64 1.56 1.61 1.61 217,918
Oct 21, 2025 1.73 1.78 1.60 1.64 1.64 453,249
Oct 20, 2025 1.55 1.67 1.54 1.65 1.65 412,659
Oct 17, 2025 1.63 1.63 1.50 1.50 1.50 353,919
Oct 16, 2025 1.66 1.71 1.58 1.65 1.65 498,817
Oct 15, 2025 1.73 1.78 1.66 1.66 1.66 446,029
Oct 14, 2025 1.78 1.79 1.66 1.70 1.70 525,600
Oct 13, 2025 1.70 1.90 1.55 1.85 1.85 750,966
Oct 10, 2025 1.94 1.94 1.61 1.64 1.64 835,781
Oct 9, 2025 2.01 2.01 1.88 1.94 1.94 385,039
Oct 8, 2025 1.83 2.06 1.83 1.97 1.97 488,836
Oct 7, 2025 2.12 2.14 1.81 1.83 1.83 772,461
Oct 6, 2025 2.22 2.27 2.10 2.11 2.11 494,696
Oct 3, 2025 1.91 2.24 1.91 2.18 2.18 1,073,489
Oct 2, 2025 1.80 1.91 1.75 1.91 1.91 888,943
Oct 1, 2025 1.82 1.86 1.75 1.81 1.81 286,404
Sep 30, 2025 1.73 1.83 1.71 1.83 1.83 214,283
Sep 29, 2025 1.89 1.90 1.72 1.75 1.75 437,803
Sep 26, 2025 1.76 1.89 1.66 1.87 1.87 700,468
Sep 25, 2025 1.53 1.84 1.52 1.79 1.79 1,677,588
Sep 24, 2025 1.28 1.57 1.27 1.55 1.55 1,566,476
Sep 23, 2025 1.25 1.32 1.24 1.26 1.26 599,827
Sep 22, 2025 1.22 1.28 1.13 1.27 1.27 739,128

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
ALX Oncology Holdings Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ALXO, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation